Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study-Reference-Cited by-同舟云学术

Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study

Published:2016-09-30 Issue:2 Volume:43 Page:166-171
ISSN:0929-5305
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Mantha Simon^ORCID,Laube Eva,Miao Yimei,Sarasohn Debra M.,Parameswaran Rekha,Stefanik Samantha,Brar Gagandeep,Samedy Patrick,Wills Jonathan,Harnicar Stephen,Soff Gerald A.

Funder

Janssen Pharmaceuticals

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

http://link.springer.com/content/pdf/10.1007/s11239-016-1429-1.pdf

Reference17 articles.

1. Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH (2007) Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 5(3):632–634. doi: 10.1111/j.1538-7836.2007.02374.x

2. Khorana AA, Dalal M, Lin J, Connolly GC (2013) Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States. Cancer 119(3):648–655. doi: 10.1002/cncr.27772

3. Khorana AA, Carrier M, Garcia DA, Lee AY (2016) Guidance for the prevention and treatment of cancer-associated venous thromboembolism. J Thromb Thrombolysis 41(1):81–91. doi: 10.1007/s11239-015-1313-4

4. Lee AY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, Rickles FR, Julian JA, Haley S, Kovacs MJ, Gent M, Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer Investigators (2003) Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 349 (2):146–153. doi: 10.1056/NEJMoa025313

5. Hull RD, Pineo GF, Brant RF, Mah AF, Burke N, Dear R, Wong T, Cook R, Solymoss S, Poon MC, Raskob G, LITE Trial Investigators (2006) Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer. Am J Med 119(12):1062–1072. doi: 10.1016/j.amjmed.2006.02.022

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pancreatic Cancer and Venous Thromboembolism;International Journal of Molecular Sciences;2024-05-23

2. Rivaroxaban bei tumorassoziierter venöser Thromboembolie;TumorDiagnostik & Therapie;2023-08-29

3. Comparison of Performances among Four Bleeding-Prediction Scores in Elderly Cancer Patients with Venous Thromboembolism;Hämostaseologie;2023-05-03

4. A retrospective evaluation of direct oral anticoagulant (DOAC) management strategies in patients with cancer on active chemotherapy;Journal of Thrombosis and Thrombolysis;2023-02-12

5. Rivaroxaban bei tumorassoziierter venöser Thromboembolie;DMW - Deutsche Medizinische Wochenschrift;2022-11